Nabriva Therapeutics plcNabriva Therapeutics plcNabriva Therapeutics plc

Nabriva Therapeutics plc

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
3.00USD
‪−57.19 M‬USD
‪36.94 M‬USD
‪3.02 M‬
Beta (1Y)
215.95

About Nabriva Therapeutics plc

CEO
H. Michael Hogan
Headquarters
Dublin
Employees (FY)
39
Founded
2017
ISIN
IE000OZRGNV6
FIGI
BBG00GPWJ425
Nabriva Therapeutics Plc is a biopharmaceutical company, which engages in the commercialization and development of novel anti-infective agents to treat infections. The company was founded in October 2005 and is headquartered in Dublin, Ireland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of NBRVF is 0.000001 USD — it hasn't changed in the past 24 hours. Watch Nabriva Therapeutics plc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Nabriva Therapeutics plc stocks are traded under the ticker NBRVF.
NBRVF stock hasn't changed in a week, the month change is a 99.00% fall, over the last year Nabriva Therapeutics plc has showed a 100.00% decrease.
NBRVF reached its all-time high on Sep 18, 2015 with the price of 4370.000000 USD, and its all-time low was 0.000001 USD and was reached on Nov 29, 2023. View more price dynamics on NBRVF chart.
See other stocks reaching their highest and lowest prices.
NBRVF stock is 0% volatile and has beta coefficient of 215.95. Track Nabriva Therapeutics plc stock price on the chart and check out the list of the most volatile stocks — is Nabriva Therapeutics plc there?
Yes, you can track Nabriva Therapeutics plc financials in yearly and quarterly reports right on TradingView.
Nabriva Therapeutics plc is going to release the next earnings report on Aug 1, 2024. Keep track of upcoming events with our Earnings Calendar.
No, NBRVF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 2, 2024, the company has 39.00 employees. See our rating of the largest employees — is Nabriva Therapeutics plc on this list?
Like other stocks, NBRVF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Nabriva Therapeutics plc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Nabriva Therapeutics plc technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Nabriva Therapeutics plc stock shows the sell signal. See more of Nabriva Therapeutics plc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.